Business Context and Reporting Period
This Form 8-K is a current report filed by Midstates Petroleum Company, Inc. (the "Company") on October 4, 2013, regarding events occurring on October 3, 2013. The filing discloses the departure of a senior executive and the terms of his separation agreement.
Key Financial Metrics
The filing does not provide general financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific severance package for the departing executive:
- Lump Sum Severance: $88,000 (contingent on execution of a waiver and release).
- Salary Continuation: Payments for a period of 18 months following separation.
- Short-Term Incentive Plan: Prorated award for 2013 to be paid in Q1 2014.
- Long-Term Incentive Plan (LTIP) Vesting:
- 26,923 shares from the April 25, 2012 grant will vest on April 25, 2014.
- 30,000 shares from the February 21, 2013 grant will vest on February 21, 2014.
- Forfeitures: 80,769 unvested shares from the 2012 grant and 105,000 unvested shares from the 2013 grant will be forfeited.
Material Changes
The primary material change reported is the resignation of Stephen C. Pugh as Executive Vice President and Chief Operating Officer, effective October 3, 2013. This departure triggers specific changes to the Company's compensation obligations and equity vesting schedules as detailed in the Separation Agreement.
Outlook, Risks, and Contingencies
The filing outlines several contingencies and contractual provisions associated with the executive's departure:
- Conditions Precedent: The lump sum severance payment is contingent upon Mr. Pugh executing a waiver and release.
- Restrictive Covenants: The agreement includes non-competition, non-solicitation, and non-disparagement provisions.
- Health Benefits: Provisions exist for the reimbursement of continued health insurance coverage.
- Future Payments: The Company anticipates cash outflows for salary continuation over 18 months and potential bonus payments in Q1 2014.
Investor Verification Checklist
- Verify the execution of the waiver and release to confirm the $88,000 lump sum liability.
- Review the full Separation and Release Agreement (Exhibit 10.1) for details on non-compete scope and health reimbursement terms.
- Monitor Q1 2014 financial statements for the prorated short-term incentive payment.
- Track the vesting dates (February 21, 2014, and April 25, 2014) for the remaining restricted stock awards.
- Confirm the appointment of a replacement for the Executive Vice President and Chief Operating Officer role.